PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Pactiv Evergreen Inc. (NASDAQ: PTVE) (“Pactiv”) on behalf of the company’s shareholders.
Pactiv shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or online at https://kaskelalaw.com/case/pactiv-evergreen/, to receive additional information about this investigation and their legal rights and options.
On December 9, 2024, Pactiv announced that it had agreed to be acquired by Novolex at a price of $18.00 per share in cash. Following the closing of the proposed transaction, Pactiv’s stockholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.
Kaskela Law LLC’s investigation seeks to determine whether $18.00 per share represents adequate consideration for Pactiv’s shares, and if the proposed transaction as currently structured is fair to Pactiv’s stockholders.
Pactiv shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 to receive additional information about this investigation and their legal rights and options. Alternatively, investors may submit their information to the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser):
https://kaskelalaw.com/case/pactiv-evergreen/
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
This notice may constitute attorney advertising in certain jurisdictions.
